Stock A222040 COSMAX NBT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Cosmax Nbt, Inc.

Equities

A222040

KR7222040008

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-02 pm EDT 		5-day change 1st Jan Change
3,925 KRW -0.88% Intraday chart for Cosmax Nbt, Inc. +0.64% -38.86%
2023 Tranche Update on Cosmax Nbt, Inc.'s Equity Buyback Plan announced on June 27, 2023. CI
2023 Tranche Update on Cosmax Nbt, Inc.'s Equity Buyback Plan announced on June 27, 2023. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tranche Update on Cosmax Nbt, Inc.'s Equity Buyback Plan announced on June 27, 2023.
CI
Tranche Update on Cosmax Nbt, Inc.'s Equity Buyback Plan announced on June 27, 2023.
CI
Cosmax Nbt, Inc.'s Equity Buyback announced on June 27, 2023, has closed with 169,491 shares, representing 0.82% for KRW 1,006.06 million.
CI
Cosmax Nbt, Inc. announces an Equity Buyback for 169,491 shares.
CI
Cosmax Nbt, Inc. authorizes a Buyback Plan.
CI
Cosmax Nbt, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Synbio Tech Inc. and Cosmax Group Signs an Exclusive Cooperation Agreement to Jointly Expand the South Korean Probiotics Market
CI
Cosmax Nbt, Inc.(KOSDAQ:A222040) dropped from S&P Global BMI Index
CI
Holzapfel Effective Microbes Co., Ltd. announced that it expects to receive KRW 10.90002816 billion in funding from Friend Investment Partners Co., Ltd., Cosmax Nbt, Inc., Amorepacific Corporation, Pyxis Innovations, Inc., GU Equity Partners LLC and another investor
CI
Nutribiotech Australia Pty. Ltd. announced that it has received AUD 10 million in funding from Cosmax Nbt, Inc.
CI
Cosmax NBT announced that it has received KRW 10.5822 billion in funding from Cosmax Nbt, Inc.
CI
NutriBiotech Co., Ltd. cancelled the acquisition of Nutribiotech Australia Pty. Ltd.
CI
NutriBiotech Co., Ltd.(KOSDAQ:A222040) added to Russell Global Index
CI
NutriBiotech Co., Ltd.(KOSDAQ:A222040) added to S&P Global BMI Index
CI
NutriBiotech Co., Ltd. agreed to acquire Nutribiotech Australia Pty. Ltd for KRW 8.6 billion
CI
Nutribiotech USA, Inc. announced that it has received $3.7 million in funding from NutriBiotech Co., Ltd..
CI
Nutribiotech USA, Inc. announced that it expects to receive $3.7 million in funding from NutriBiotech Co., Ltd..
CI
NutriBiotech Co., Ltd. has completed an IPO in the amount of KRW 43.68 billion.
CI
NutriBiotech Co., Ltd. has filed an IPO in the amount of 39.10 billion.
CI
Cosmax BTI, Inc. completed the acquisition of 40.7% stake in Nutribiotech Co., Ltd. from Kaffa Int Co. Limited.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A222040 Stock
  4. News Cosmax Nbt, Inc.